Feba Bennya,
Jong Min Ohb,
Sunil Kumara,
Mohamed A. Abdelgawadc,
Mohammed M. Ghoneimd,
Mohamed Sadek Abdel-Bakkye,
Neelima Kukertif,
Jobin Joseg,
Hoon Kim*b and
Bijo Mathew*a
aDepartment of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682041, India. E-mail: febacbenny@gmail.com; solankimedchem@gmail.com; bijovilaventgu@gmail.com; bijomathew@aims.amrita.edu
bDepartment of Pharmacy, Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea. E-mail: ddazzo005@naver.com; hoon@sunchon.ac.kr
cDepartment of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia. E-mail: mhmdgwd@ju.edu.sa
dDepartment of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah 13713, Saudi Arabia. E-mail: mghoneim@mcst.edu.sa
eDepartment of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia. E-mail: abdelbakkym@yahoo.com
fSchool of Pharmacy, Graphic Era Hill University, Dehradun, Uttarakhand 248002, India. E-mail: nkukreti@gehu.ac.in
gDepartment of Pharmaceutics, NGSM Institute of Pharmaceutical Science, NITTE University, Mangalore, Karnataka 575018, India. E-mail: jjmattam07@gmail.com
First published on 2nd January 2024
Correction for ‘Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurodegenerative disease treatment’ by Feba Benny et al., RSC Adv., 2023, 13, 35240–35250, https://doi.org/10.1039/D3RA07035B.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2024 |